Prof. Dr. Burak ŞAKAR

Yayın Ağı

Makaleler 11

1. Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

Dogan I., Tastekin D., Karabulut S., Sakar B.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.3, 2021 (SCI-Expanded)

2. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy

Aykan N. F., Yildiz I., Sen F., Kilic L., Keskin S., Ciftci R., et al.

MEDICAL ONCOLOGY , cilt.30, sa.3, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

3. A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma

Saglam S., Aykan N. F., ŞAKAR B., GÜLLÜOĞLU M., Balik E., Karanlik H.

JOURNAL OF GASTROINTESTINAL ONCOLOGY , cilt.2, sa.1, ss.19-26, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

4. Clinical outcome of rhabdomyosarcoma in adolescent and adult patients: Single center experience from Turkey

Ustuner Z., Basaran M., Dizdar Y., Agaoglu F. Y., Bilgic B., Sakar B., et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE , cilt.213, sa.3, ss.221-229, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

5. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas

Basaran M., Bavbek E. S., Saglam S., Eralp L., Sakar B., Atalar A. C., et al.

ONCOLOGY , cilt.72, ss.255-260, 2007 (SCI-Expanded)

6. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.

TAS F., USTUNER Z., CAN G., ERALP Y., CAMLICA H., BASARAN M., et al.

Acta oncologica (Stockholm, Sweden) , cilt.44, sa.2, ss.161-7, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Ewing's sarcoma of the axial system in patients older than 15 years: Dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment

Argon A., Basaran M., Yaman F., Dizdar Y., Sakar B., Camlica H., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.34, sa.11, ss.667-672, 2004 (SCI-Expanded)

8. Clinicopathologic factors influencing survival of patients with bile duct and gallbladder carcinoma

Sakar B., Basaran M., Gumus M., Yazar A., Argon A., Aykan N. F.

ANNALS OF ONCOLOGY , cilt.15, ss.243-244, 2004 (SCI-Expanded)

9. Colorectal cancer in young patients: Characteristics and outcome

Alici S., Aykan N., ŞAKAR B., Bulutlar G., Kaytan E., Topuz E.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE , cilt.199, sa.2, ss.85-93, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

10. A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer

Başaran M., Bavbek S., Güllü İ., Demirelli F. H., Şakar B., Tenekeci N., et al.

JOURNAL OF CHEMOTHERAPY , cilt.14, ss.207-213, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

11. Hypertrophic osteoarthropathy associated with docetaxel treatment.

Tas F., Aydiner A., Tenekeci N., Karadeniz A. N., Sakar B., Topuz E.

Clinical oncology (Royal College of Radiologists (Great Britain)) , cilt.13, sa.2, ss.145-6, 2001 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. Do serum nectin-2 levels have a prognostic effect in patients with colorectal cancer?

Basaran M., KARABULUT S., KARABULUT M., GUNALDI M., ALIS H., Erturk K., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

150

H-İndeks (WoS)

Atıf (Scopus)

144

H-İndeks (Scopus)

BM Sürdürülebilir Kalkınma Amaçları